0
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.19.47.197. Please contact the publisher to request reinstatement.
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Quality of Life of Adult Patients With Attention-Deficit/Hyperactivity Disorder Taking Methylphenidate—Reply

Alexandra Philipsen, MD1; Ludger Tebartz van Elst, MD2; Erika Graf, PhD3
[+] Author Affiliations
1Medical Campus University of Oldenburg, School of Medicine and Health Sciences, Psychiatry and Psychotherapy–University Hospital, Karl-Jaspers-Klinik, Bad Zwischenahn, Germany
2Department of Psychiatry and Psychotherapy, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany
3Clinical Trials Unit, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany
JAMA Psychiatry. 2016;73(5):534-535. doi:10.1001/jamapsychiatry.2016.0051.
Text Size: A A A
Published online

Extract

In Reply We thank Boesen and Gøtzsche for recognizing our research efforts and for the opportunity to respond to their letter on our article.1

First and foremost, Boesen and Gøtzsche criticize the article for omitting detailed information on adverse events (AEs) and quality-of-life data. However, we believe the wealth of data this challenging landmark trial generated, if presented in detail, would require more space than is available in our presentation of the main results—the 2 × 2 design required reporting for both psychotherapeutic and medical interventions.1 Therefore, we had planned to publish separate reports on AEs and further secondary outcomes, including quality of life, and they are currently in preparation. We made this clear by stating that the secondary outcomes included those reported in JAMA Psychiatry1 and by referring readers to the publication of the study protocol.2 Although we appreciate the interest in further results, their absence from the current report is not owing to reporting bias.

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

May 1, 2016
Kim Boesen, MD; Peter C. Gøtzsche, DMSci
1The Nordic Cochrane Centre, Copenhagen, Denmark
JAMA Psychiatry. 2016;73(5):533-534. doi:10.1001/jamapsychiatry.2016.0049.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

307 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Jobs
brightcove.createExperiences();